The financials
BioAge Labs, Inc. by the numbers
BioAge Labs, Inc. (BIOA) reported revenue of $2.8M in Q1 2026 (quarter ended March 31, 2026), up 91% from the same quarter a year earlier. That came with net loss of $22M. For the full year FY2025, revenue was $9.0M and net income −$81M.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $2.8M | $1.5M | +91% |
| Operating income | −$25M | −$16M | n/a |
| Net income | −$22M | −$13M | n/a |
| Diluted EPS | −$0.52 | −$0.36 | n/a |
Drug Manufacturers - Specialty & Generic
The closest names by size in the same industry